These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 3583393)
21. Disposition of new sulphur-containing 2-(chloroethyl)nitrosoureas in rats. Godenèche D; Madelmont JC; Labarre P; Plagne R; Meyniel G Xenobiotica; 1987 Jan; 17(1):59-70. PubMed ID: 3825177 [TBL] [Abstract][Full Text] [Related]
22. Synthesis of some substituted pyrimidines as possible anti-cancer agents. Ganu UK; Ambaye RY; Bhat ML; Panse TB Indian J Cancer; 1981 Sep; 18(3):176-80. PubMed ID: 7309121 [No Abstract] [Full Text] [Related]
23. Carcinogenicity of nitrosoureas in humans. Preussmann R IARC Sci Publ; 1986; (78):223-9. PubMed ID: 3583392 [TBL] [Abstract][Full Text] [Related]
24. A new comprehensive technique of catheterisation, blood sampling, sample preparation and sample analysis by means of high-pressure liquid chromatography for pharmacokinetic studies with estradiol-linked nitrosoureas and their metabolites. Betsch B; Berger MR; Spiegelhalder B Arzneimittelforschung; 1990 Sep; 40(9):1022-5. PubMed ID: 2080936 [TBL] [Abstract][Full Text] [Related]
25. Chemotherapeutic activity of new 2-chloroethylnitrosoureas in rat L5222 leukemia: comparison of bifunctional and water-soluble derivatives with 1,3-bis(2-chloroethyl)-1-nitrosourea. Zeller WJ; Eisenbrand G; Fiebig HH J Natl Cancer Inst; 1978 Feb; 60(2):345-8. PubMed ID: 621753 [TBL] [Abstract][Full Text] [Related]
26. Unexpected genetic toxicity to rodents of the N',N'-dimethyl analogues of MNU and ENU. Tinwell H; Paton D; Guttenplan JB; Ashby J Environ Mol Mutagen; 1996; 27(3):202-10. PubMed ID: 8625956 [TBL] [Abstract][Full Text] [Related]
27. Anticancer Drug Development: The Way Forward. Connors T Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985 [TBL] [Abstract][Full Text] [Related]
28. Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agents. Schmid FA; Otter GM; Mehta BM Cancer Res; 1985 Jan; 45(1):40-4. PubMed ID: 3965147 [TBL] [Abstract][Full Text] [Related]
29. Carcinogenicity of hydroxylated alkylnitrosoureas and of nitrosooxazolidones by mouse skin painting and by gavage in rats. Lijinsky W; Reuber MD Cancer Res; 1983 Jan; 43(1):214-21. PubMed ID: 6847770 [TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and biological evaluation of DNA sequence and minor groove selective alkylating agents. Lee M; Rhodes AL; Wyatt MD; Forrow S; Hartley JA Anticancer Drug Des; 1993 Jun; 8(3):173-92. PubMed ID: 8517912 [TBL] [Abstract][Full Text] [Related]
31. Synthesis, acute toxicity and chemotherapeutic anti-cancer activities of a new tripeptidic mustard. De Barbieri A; Dall'Asta L; Comini A; Springolo V; Mosconi P; Coppi G Farmaco Sci; 1983 Apr; 38(4):205-18. PubMed ID: 6861998 [TBL] [Abstract][Full Text] [Related]
32. [The biochemical mechanisms of the action of N-alkyl-N-nitrosoureas. The possible reasons for drug resistance to these compounds]. Syrkin AB; Gorbacheva LB Eksp Klin Farmakol; 1996; 59(2):69-75. PubMed ID: 8974572 [TBL] [Abstract][Full Text] [Related]
33. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids. Lippert B Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842 [TBL] [Abstract][Full Text] [Related]
34. DNA-Directed alkylating agents. 7. Synthesis, DNA interaction, and antitumor activity of bis(hydroxymethyl)- and bis(carbamate)-substituted pyrrolizines and imidazoles. Atwell GJ; Fan JY; Tan K; Denny WA J Med Chem; 1998 Nov; 41(24):4744-54. PubMed ID: 9822545 [TBL] [Abstract][Full Text] [Related]
35. Leukemia: A model for drug development. Keating MJ Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2598-604. PubMed ID: 9815664 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and antitumour activity of several new 4-aroyl-1-nitrosohydrazinecarboxamides. Gugova R; Topakbashian V; Lozeva S; Dimov S; Golovinsky E Drugs Exp Clin Res; 1997; 23(2):71-5. PubMed ID: 9309382 [TBL] [Abstract][Full Text] [Related]
37. Comparison of new nitrosoureas esters with modified steroidal nucleus for cytogenetic and antineoplastic activity. Hussein A; Mioglou-Kalouptsi E; Papageorgiou A; Karapidaki I; Iakovidou-Kritsi Z; Lialiaris T; Xrysogelou E; Camoutsis C; Mourelatos D In Vivo; 2007; 21(2):389-95. PubMed ID: 17436593 [TBL] [Abstract][Full Text] [Related]
38. Chemotherapeutic activity of 2-chloroethylnitrosocarbamoyl derivatives of amino acids in a transplanted rat leukemia (L 5222). Zeller WJ; Berger M; Eisenbrand G; Tang W; Schmähl D Arzneimittelforschung; 1982; 32(5):484-6. PubMed ID: 7201823 [TBL] [Abstract][Full Text] [Related]
39. Elevated DNA polymerase alpha, DNA polymerase beta, and DNA topoisomerase II in a melphalan-resistant rhabdomyosarcoma xenograft that is cross-resistant to nitrosoureas and topotecan. Friedman HS; Dolan ME; Kaufmann SH; Colvin OM; Griffith OW; Moschel RC; Schold SC; Bigner DD; Ali-Osman F Cancer Res; 1994 Jul; 54(13):3487-93. PubMed ID: 8012971 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of human O6-alkylguanine-DNA alkyltransferase and potentiation of the cytotoxicity of chloroethylnitrosourea by 4(6)-(benzyloxy)-2,6(4)-diamino-5-(nitro or nitroso)pyrimidine derivatives and analogues. Terashima I; Kohda K J Med Chem; 1998 Feb; 41(4):503-8. PubMed ID: 9484500 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]